31.32
price down icon4.72%   -1.55
after-market 시간 외 거래: 32.81 1.49 +4.76%
loading

왜 Revolution Medicines Inc (RVMD) 주가가 하락하고 있습니까?

2025-04-03 거래 세션 동안 Revolution Medicines Inc(RVMD) 주식이 5.00% 하락한 것을 확인했습니다. 이는 정상적인 변동성이나 다양한 내부 및 외부 요인에 의한 것일 수 있지만, 상황을 적극적으로 모니터링하고 있으며 최대한 빨리 적시에 업데이트를 제공하도록 하겠습니다!
2023-10-23:

Shares of Revolution Medicines (RVMD) dropped by 34.38% from $27.97 to $18.36 in the trading on Monday, October 23, 2023. The reason why RVMD stock down is due to the release of data from their RMC-6236 phase 1 study targeting NSCLC and PDAC treatment at the ESMO Congress in Madrid. Expectations were high, with RVMD's stock having risen over 40% year-to-date just the previous week. However, RMC-6236's performance disappointed, with an objective response rate of only 30% in NSCLC after unconfirmed responses were excluded. In PDAC, only 19.6% of patients achieved a partial response, with four of them being unconfirmed. RVMD's CEO expressed confidence in RMC-6236, but analyst Jonathan Chang noted that the results may have fallen short of investor expectations.

$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
자본화:     |  볼륨(24시간):